Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea

Sponsor
Cairo University
Study ID
NCT07447011
Status
Recruiting
Apply to this trial

Conditions

  • Obesity
  • Obstructive Sleep Apnea
  • Primary Open Angle Glaucoma

Eligibility Criteria

Sex
ALL
Age
30 Years - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • lifetyle corrections and CPAP — BEHAVIORAL
    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
  • CPAP — OTHER
    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.

Study Details

glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended

Key Dates

First listed
Mar 3, 2026
Start date
Feb 4, 2026
Status verified
Feb 2026
Primary completion
Jul 20, 2026
Completion
Jul 20, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: group number 1
    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
  • Active Comparator: group number 2
    twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.

Primary Outcome Measure

Intraocular pressure [ Time Frame: it will be measured after 12 weeks ]

Central Contacts

Find similar trials

Nationwide
Obesity / overweight trialsEndocrinology trialsMetabolic health trialsWeight loss trials

Related Studies